EPO and Renal insufficiency: Furthermore, sub-analysis of the Correlation of Hemoglobin and Outcomes in Renal Insufficiency (CHIOR) trial revealed that a higher dose of epoetin-α (>10,095 units/week) was associated with an increased risk of cardiovascular events [16].